.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Dow
US Department of Justice
Citi
Healthtrust
Chubb
Boehringer Ingelheim
Fish and Richardson
Julphar
Accenture

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206439

« Back to Dashboard
NDA 206439 describes NAMZARIC, which is a drug marketed by Forest Labs Llc and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug and one Paragraph IV challenge. Additional details are available on the NAMZARIC profile page.

The generic ingredient in NAMZARIC is donepezil hydrochloride; memantine hydrochloride. There are thirty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the donepezil hydrochloride; memantine hydrochloride profile page.

Summary for NDA: 206439

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 206439

Suppliers and Packaging for NDA: 206439

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NAMZARIC
donepezil hydrochloride; memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL 206439 NDA Allergan, Inc. 0456-1207 0456-1207-30 30 CAPSULE in 1 BOTTLE (0456-1207-30)
NAMZARIC
donepezil hydrochloride; memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL 206439 NDA Allergan, Inc. 0456-1214 0456-1214-11 10 CAPSULE in 1 BLISTER PACK (0456-1214-11)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength10MG;14MG
Approval Date:Dec 23, 2014TE:ABRLD:Yes
Patent:8,039,009*PEDPatent Expiration:Sep 24, 2029Product Flag?Substance Flag?Delist Request?Y
Patent:8,168,209*PEDPatent Expiration:May 22, 2026Product Flag?Substance Flag?Delist Request?Y
Patent:8,173,708*PEDPatent Expiration:May 22, 2026Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 206439

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Forest Labs Llc
NAMZARIC
donepezil hydrochloride; memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL206439-001Dec 23, 20145,061,703*PED► Subscribe
Forest Labs Llc
NAMZARIC
donepezil hydrochloride; memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL206439-002Dec 23, 20145,061,703*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Deloitte
Dow
Federal Trade Commission
Merck
Chinese Patent Office
Accenture
Daiichi Sankyo
Fish and Richardson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot